Obstructive sleep apnea syndrome
Conditions
Interventions
Control Group:Basic treatment + Nasal Continuous Positive Airway Pressure (CPAP)
Observation Group:Basic treatment + Nasal Continuous Positive Airway Pressure (CPAP) + Modified Hanzheng Formula
Sponsors
Fangta Traditional Chinese Medicine Hospital of Songjiang District of Shanghai
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meets the Western medicine diagnostic criteria and the TCM diagnostic criteria for Qi deficiency and phlegm stasis syndrome; (2) Age 35-65 years, body mass index 24-32 kg/m²; (3) Has not received nasal continuous positive airway pressure ventilation, TCM or other targeted treatments for obstructive sleep apnea syndrome within the past month; (4) Expected survival = 6 months, able to cooperate to complete 4 weeks of treatment and follow-up; (5) Voluntarily participates in this study and signs informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with central or mixed sleep apnea syndrome; (2) Patients with combined upper airway organic lesions such as nasal polyps, laryngeal cancer, etc., requiring surgical treatment; (3) Patients with severe heart failure, liver and kidney failure or coagulation disorders; (4) Patients allergic to or intolerant to nasal continuous positive airway pressure ventilation for the TCM components studied in this study; (5) Pregnant or lactating women or patients with mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Clinical Effectiveness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nocturnal Polysomnography Indicators;Traditional Chinese Medicine Syndrome Score;Epworth Sleepiness Scale Score;Complete Blood Count Indicators;Adverse Reaction Rate; | — |
Countries
China
Contacts
Public ContactZheng Yuxin
Fangta Traditional Chinese Medicine Hospital of Songjiang District of Shanghai
Outcome results
None listed